Brief: Milestone Pharmaceuticals Reports Q3 Loss Of $0.34 Per Share
10/11/2022 13:03
Nov 10 (Reuters) - Milestone Pharmaceuticals Inc
MIST.O :
* MILESTONE PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CLINICAL AND CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.34
* Q3 EARNINGS PER SHARE VIEW $-0.41 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn1THsYsa
Further company coverage: MIST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Milestone Pharmaceuticals
See all newsBrief: Milestone Pharmaceuticals Announces First European Study Participant Enrolled In Revera-301 Phase 3 Clinical Trial
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview